• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.53% Nasdaq Down0.76%

    Becton, Dickinson and Company (BDX)

    -NYSE
    161.41 Up 0.98(0.61%) 1:34PM EDT - Nasdaq Real Time Price
    ProfileGet Profile for:
    Becton, Dickinson and Company
    1 Becton Drive
    Franklin Lakes, NJ 07417
    United States - Map
    Phone: 201-847-6800
    Website: http://www.bd.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:49,517

    Business Summary 

    Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; generic prefilled injectables; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation, and diagnostics equipment and consumables; and consumables for patient monitoring and anesthesia delivery. Its Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women’s health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Investor Relations
    Employment
    Subsidiaries
    Search Yahoo! for:
    More on Becton, Dickinson and Company

    Corporate Governance 
    Becton, Dickinson and Company’s ISS Governance QuickScore as of May 1, 2016 is 3. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 6; Compensation: 2.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Vincent A. Forlenza , 63
    Chairman, Chief Exec. Officer, Pres and Chairman of Exec. Committee
    2.75M0.00
    Mr. Christopher R. Reidy , 59
    Chief Financial Officer, Chief Admin. Officer and Exec. VP
    1.48M0.00
    Mr. Jeffrey S. Sherman Esq., 61
    Exec. VP and Gen. Counsel
    1.07M671.00K
    Dr. Ellen R. Strahlman M.D., M.H.Sc., 59
    Chief Medical Officer and Exec. VP of R&D
    1.27M0.00
    Mr. John E. Gallagher , 43
    Sr. VP of Corp. Fin., Treasurer and Controller
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders